Sentences with phrase «cell neoplasm»
The phrase "cell neoplasm" refers to an abnormal and uncontrolled growth of cells in the body. It generally refers to a tumor or cancerous growth. Full definition
Early Onset, EBV - PTLD in Pediatric Liver - Small Bowel Transplantation Recipients: A Spectrum of Plasma Cell Neoplasms with Favorable Prognosis.
invivoscribe.com
«Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123 - Specific CAR T Cells: A First - in - Human Clinical Trial» is presented at the ASH Annual Meeting Dec. 9 to 12, 2017.
Mice have a high incidence of Hodgkin's - like reticulum cell neoplasm at 18 months of age and pituitary tumors in old multiparous females.
Mehlhaff CJ, Peterson ME, Patnaik AK, Carrillo JM: Insulin producing islet cell neoplasms: Surgical considerations and general management in 35 dogs.
Supportive care is given to treat problems caused by multiple myeloma and other plasma cell neoplasms.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very aggressive type of cancer with multiple manifestations including skin lesions, abnormal cell counts and central nervous system (CNS) disease involvement.
Daratumumab and elotuzumab are monoclonal antibodies used in the treatment of multiple myeloma and other plasma cell neoplasms.
In this type of plasma cell neoplasm, the abnormal plasma cells (myeloma cells) are in one place and form one tumor, called a plasmacytoma.
External radiation therapy is used to treat plasma cell neoplasms.
Several types of targeted therapy may be used to treat multiple myeloma and other plasma cell neoplasms.
In this type of plasma cell neoplasm, less than 10 % of the bone marrow is made up of abnormal plasma cells and there is no cancer.
Plasma cell neoplasms are diseases in which abnormal plasma cells or myeloma cells form tumors in the bones or soft tissues of the body.
Panobinostat is an HDAC inhibitor used in the treatment of multiple myeloma and other plasma cell neoplasms.
For more information from the National Cancer Institute about multiple myeloma and other plasma cell neoplasms, see the following:
Bortezomib, carfilzomib, and ixazomib are proteasome inhibitors used in the treatment of multiple myeloma and other plasma cell neoplasms.
Plasma cell neoplasms are most common in people who are middle aged or older.
The following types of plasma cell neoplasms are cancer:
Thalidomide, lenalidomide, and pomalidomide are immunomodulators used to treat multiple myeloma and other plasma cell neoplasms.
Different types of treatments are available for patients with plasma cell neoplasms.
Multiple myeloma and other plasma cell neoplasms (cancers) are diseases in which the body makes too many plasma cells.